Adding Beach Body (BODY) $3.90 to the Watch List.
This is Like Shooting Fish in the Barrell, but the Fish Shoot Back.
We’re not traders, but we...
And We Have Our First MEME Stock! $2.00 to $29.95.
Tiny U.S. Biotech Jumps 930% as It Picks Up Retail Attention (Bloomberg)
Guess we were bound to stumble across...
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Society Pass News Archive
1-24-2023: Initiating Coverage on Society Pass (SOPA).
1-24-2023: Society Pass (SOPA) Research Reports
1-12-2023: Adding Society...
Telehealth Watch List.
We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.
OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share.
Without disrupting legacy sales - CEO Shai...
Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.
New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks
Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic...
Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company
WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE
What exactly is a favorite?
First...
Hapbee (HAPB) Adds 18 New Signal Blends in Major Expansion of Its Digital Wellness...
Hapbee now comes bundled with "lifetime blends" and offers an all-access subscription option.
VANCOUVER, BC, Sept. 20, 2021 /PRNewswire/ - Hapbee Technologies,...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
